 |
5 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- Nepadutant (MEN 11420) / Menarini
Trial completion: no-cry: Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic (clinicaltrials.gov) - Mar 23, 2014
P2, N=115, Completed, Sponsor: Menarini Group
Recruiting --> Completed
- | Nepadutant (MEN 11420) / Menarini
Trial completion: Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance (clinicaltrials.gov) - Mar 23, 2014
P2, N=27, Completed, Sponsor: Menarini Group
Recruiting --> Completed Active, not recruiting --> Completed
- Nepadutant (MEN 11420) / Menarini
Trial withdrawal: nocry-a: Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment (clinicaltrials.gov) - Nov 4, 2012
P2, N=0, Withdrawn, Sponsor: Menarini Group
Active, not recruiting --> Completed Recruiting --> Withdrawn
- Nepadutant (MEN 11420) / Menarini
Enrollment change: nocry-a: Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment (clinicaltrials.gov) - Nov 4, 2012
P2, N=0, Withdrawn, Sponsor: Menarini Group
Recruiting --> Withdrawn N=30 --> 0
- | Nepadutant (MEN 11420) / Menarini
New P2 trial: Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance (clinicaltrials.gov) - Feb 12, 2012
P2, N=27, Completed, Sponsor: Menarini Group